loadpatents
name:-0.032718896865845
name:-0.027196884155273
name:-0.0049760341644287
Universite Paris-Sud XI Patent Filings

Universite Paris-Sud XI

Patent Applications and Registrations

Patent applications and USPTO patent grants for Universite Paris-Sud XI.The latest application filed is for "methods and pharmaceutical compositions for the treatment and the prevention of cardiomyopathy due to energy failure".

Company Profile
5.36.28
  • Universite Paris-Sud XI - Orsay FR
  • UNIVERSITE PARIS-SUD XI - Orsay Cedex FR
  • Universite Paris-Sud XI; - Orsay Cedex FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods And Pharmaceutical Compositions For The Treatment And The Prevention Of Cardiomyopathy Due To Energy Failure
App 20220090128 - PUCCIO; Helene Monique ;   et al.
2022-03-24
Methods And Pharmaceutical Composition For The Treatment And The Prevention Of Cardiomyopathy Due To Energy Failure
App 20210340565 - PUCCIO; Helene Monique ;   et al.
2021-11-04
Single-component artificial neuron based on Mott insulators, network of artificial neurons and corresponding manufacturing method
Grant 10,867,237 - Cario , et al. December 15, 2
2020-12-15
Method for detecting the presence of expanded spectrum .beta.-lactamase-producing bacteria in a sample
Grant 10,793,892 - Nordmann , et al. October 6, 2
2020-10-06
Cryogenic Device For Magnetic Resonance Imagery Scanner And Magnetic Resonance Imagery Assembly Comprising Such Cryogenic Device
App 20200209329A1 -
2020-07-02
Methods and pharmaceutical compositions for the treatment and the prevention of cardiomyopathy due to Friedreich ataxia
Grant 10,337,027 - Puccio , et al.
2019-07-02
Methods And Pharmaceutical Composition For The Treatment And The Prevention Of Cardiomyopathy Due To Energy Failure
App 20180334687 - PUCCIO; Helene Monique ;   et al.
2018-11-22
Self-associating microparticles and nanoparticles consisting of proteins
Grant 10,111,961 - Bouchemal October 30, 2
2018-10-30
Mutated non-primate lentiviral Env proteins and their use as drugs
Grant 9,974,852 - Heidmann May 22, 2
2018-05-22
Method for the high-yield production of giant P-(R)calixarenes
Grant 9,868,809 - Huc , et al. January 16, 2
2018-01-16
Process for the high-yield preparation of P-(R)calix[9-20]arenes
Grant 9,809,523 - Huc , et al. November 7, 2
2017-11-07
Mutant human and simian immunodeficiency virus ENV proteins with reduced immunosuppressive properties
Grant 9,682,137 - Heidmann June 20, 2
2017-06-20
Single-component Artificial Neuron Based On Mott Insulators, Network Of Artificial Neurons And Corresponding Manufacturing Method
App 20170124449 - Cario; Laurent ;   et al.
2017-05-04
Mutant human and simian immunodeficiency virus ENV proteins with reduced immunosuppressive properties
Grant 9,636,396 - Heidmann May 2, 2
2017-05-02
Polypeptides As Apelin Inhibitors And Uses Thereof
App 20170114113 - SIEGFRIED; Geraldine ;   et al.
2017-04-27
Modified apelin polypeptides
Grant 9,593,153 - Siegfried , et al. March 14, 2
2017-03-14
Process For The High-yield Preparation Of P-(r)calix[9-20]arenes
App 20160368849 - HUC; Vincent, Germain ;   et al.
2016-12-22
Method for the high-yield production of P-(R-oxy)calix[9-20] arenes
Grant 9,376,362 - Huc , et al. June 28, 2
2016-06-28
Therapeutical Use Of Ternary Complexes Of Valproic Acid
App 20160166705 - SYLLA-IY ARRETA VEITIA; Maite ;   et al.
2016-06-16
Mutated Non-primate Lentiviral Env Proteins And Their Use As Drugs
App 20160129107 - HEIDMANN; Thierry
2016-05-12
Self-associating Microparticles And Nanoparticles Consisting Of Proteins
App 20160120991 - BOUCHEMAL; Kawthar
2016-05-05
Vitamin C complexes
Grant 9,295,630 - Couvreur , et al. March 29, 2
2016-03-29
Catalyst And Method For The Electrochemical Oxidation Of Methane
App 20160064743 - Lu; Yu-Wei
2016-03-03
High-yield synthesis of p-(benzyloxy)calix[6, 7,8]arenes
Grant 9,255,054 - Huc , et al. February 9, 2
2016-02-09
Methods And Pharmaceutical Composition For The Treatment And The Prevention Of Cardiomyopathy Due To Energy Failure
App 20160024526 - PUCCIO; Helene Monique ;   et al.
2016-01-28
Chemical compounds capable of complexing at least one metal element and a coordination complex based on these compounds
Grant 9,181,204 - Leibl , et al. November 10, 2
2015-11-10
Methods And Pharmaceutical Compositions For The Treatment And The Prevention Of Cardiomyopathy Due To Friedreich Ataxia
App 20150313969 - Puccio; Helene Monique ;   et al.
2015-11-05
Method For The High-yield Production Of P-(r-oxy)calix[9-20] Arenes
App 20150291494 - HUC; Vincent Germain ;   et al.
2015-10-15
Method For The High-yield Production Of Giant P-(r)calixarenes
App 20150232603 - Huc; Vincent Germain ;   et al.
2015-08-20
Magnetoresistive device
Grant 9,093,163 - Wunderlich , et al. July 28, 2
2015-07-28
Use Of Transferrin Receptor Antagonist For The Treatment Of Thalassemia
App 20150197574 - Cruz-Moura; Ivan ;   et al.
2015-07-16
Methods and pharmaceutical compositions for the treatment of cardiomyopathy due to friedreich ataxia
Grant 9,066,966 - Puccio , et al. June 30, 2
2015-06-30
Methods For Diagnosing And Treating Focal Segmental Glomerulosclerosis
App 20150140010 - Durrbach; Antoine ;   et al.
2015-05-21
Method For Characterizing Circulating Tumor Cells, And Use Thereof In Diagnosis
App 20150133323 - Barthelemy; Amelie ;   et al.
2015-05-14
Polypeptides As Apelin Inhibitors And Uses Thereof
App 20150072932 - Siegfried; Geraldine ;   et al.
2015-03-12
High-yield Synthesis Of P-(benzyloxy)calix[6, 7,8]arenes
App 20150011798 - Huc; Vincent, Germain ;   et al.
2015-01-08
Method For Detecting The Presence Of Expanded Spectrum B-lactamase-producing Bacteria In A Sample
App 20140308693 - Nordmann; Patrice ;   et al.
2014-10-16
Mutated Lentiviral Env Proteins And Their Use As Drugs
App 20140294880 - Heidmann; Thierry
2014-10-02
Mutated antithrombins, a process for preparing the same and their use as drugs
Grant 8,822,654 - Borgel , et al. September 2, 2
2014-09-02
Mutated HIV Nef for modulating immunity
Grant 8,795,685 - Renard , et al. August 5, 2
2014-08-05
Use of mutated antithrombins for treating or preventing coagulation disorders
Grant 8,741,844 - Borgel born Botbol , et al. June 3, 2
2014-06-03
Mutated env sequence involved in the modulation of the immunosuppressive effect of viral proteins
Grant 8,597,657 - Renard , et al. December 3, 2
2013-12-03
Apparatus And Method For Generating Mechanical Waves Into Living Bodies, System And Method For Mapping An Organ Or Tissue And System And Method For Characterising The Mechanical Properties Of Said Organ Or Tissue
App 20130237807 - Maitre; Xavier Francois ;   et al.
2013-09-12
Mutated Lentiviral Env Proteins And Their Use As Drugs
App 20130149323 - HEIDMANN; Thierry
2013-06-13
Device and method for information mass storage
Grant 8,385,184 - Moradpour , et al. February 26, 2
2013-02-26
Novel Method For Isolating Endotoxins
App 20120213821 - CAROFF; Martine
2012-08-23
Polypeptide sequence involved in the modulation of the immunosuppressive effect of viral proteins
Grant 8,178,657 - Renard , et al. May 15, 2
2012-05-15
Catalyst and Method for the Electrochemical Oxidation of Methane
App 20120088186 - Lu; Yu-Wei
2012-04-12
Mutated Antithrombins, A Process For Preparing The Same And Their Use As Drugs
App 20120088715 - Borgel born Botbol; Delphine ;   et al.
2012-04-12
Method for isolating endotoxins
Grant 8,137,935 - Caroff March 20, 2
2012-03-20
Method of controlling a magnetoresistive device using an electric field pulse
Grant 8,138,758 - Wunderlich , et al. March 20, 2
2012-03-20
Use Of Mutated Antithrombins For Treating Or Preventing Coagulation Disorders
App 20100298224 - Borgel born Botbol; Delphine ;   et al.
2010-11-25
Magnetic memory device
Grant 7,738,286 - Ito , et al. June 15, 2
2010-06-15
Antiviral agent for use in treatment of cancer
Grant 6,723,712 - Bourhis , et al. April 20, 2
2004-04-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed